Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent

被引：10
作者：
Suarez-Kurtz, Guilherme [1 ]
机构：
[1] Inst Nacl Canc, Div Farmacol, Rio De Janeiro, Brazil
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 67卷 / 02期
关键词：
GENOMIC ANCESTRY; DRUG-METABOLISM; POLYMORPHISMS; PHARMACOGENETICS; INHIBITORS; CYP2C19; COMMON; COLOR;
D O I：
10.1007/s00228-010-0910-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：211 / 212
页数：2
相关论文
共 16 条
  • [1] A single-nucleotide polymorphism tagging set for human drug metabolism and transport
    Ahmadi, KR
    Weale, ME
    Xue, ZYY
    Soranzo, N
    Yarnall, DP
    Briley, JD
    Maruyama, Y
    Kobayashi, M
    Wood, NW
    Spurr, NK
    Burns, DK
    Roses, AD
    Saunders, AM
    Goldstein, DB
    [J]. NATURE GENETICS, 2005, 37 (01) : 84 - 89
  • [2] CYP2C8 polymorphism among the Portuguese
    Cavaco, I
    Piedade, R
    Gil, JP
    Ribeiro, V
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) : 168 - 170
  • [3] Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
    Dai, D
    Zeldin, DC
    Blaisdell, JA
    Chanas, B
    Coulter, SJ
    Ghanayem, BI
    Goldstein, JA
    [J]. PHARMACOGENETICS, 2001, 11 (07): : 597 - 607
  • [4] Characterization of the genetic profile of CYP2C19 in two South African populations
    Drogemoeller, Britt I.
    Wright, Galen E. B.
    Niehaus, Dana J. H.
    Koen, Liezl
    Malan, Stefanie
    Da Silva, Danielle M.
    Hillermann-Rebello, Renate
    La Grange, Anthony M.
    Venter, Mauritz
    Warnich, Louise
    [J]. PHARMACOGENOMICS, 2010, 11 (08) : 1095 - 1103
  • [5] Cubic exact solutions for the estimation of pairwise haplotype frequencies:: implications for linkage disequilibrium analyses and a web tool 'CubeX'
    Gaunt, Tom R.
    Rodriguez, Santiago
    Day, Ian N. M.
    [J]. BMC BIOINFORMATICS, 2007, 8 (1)
  • [6] Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
    Ingelman-Sundberg, Magnus
    Sim, Sarah C.
    Gomez, Alvin
    Rodriguez-Antona, Cristina
    [J]. PHARMACOLOGY & THERAPEUTICS, 2007, 116 (03) : 496 - 526
  • [7] Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
    Kudzi, William
    Dodoo, Alexander N. O.
    Mills, Jeremy J.
    [J]. BMC MEDICAL GENETICS, 2009, 10
  • [8] Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
    Li-Wan-Po, Alain
    Girard, Thierry
    Farndon, Peter
    Cooley, Candy
    Lithgow, James
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (03) : 222 - 230
  • [9] Amodiaquine metabolism is impaired by common polymorphisms inCYP2C8: Implications for malaria treatment in Africa
    Parikh, S.
    Ouedraogo, J-B
    Goldstein, J. A.
    Rosenthal, P. J.
    Kroetz, D. L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (02) : 197 - 203
  • [10] Color and genomic ancestry in Brazilians
    Parra, FC
    Amado, RC
    Lambertucci, JR
    Rocha, J
    Antunes, CM
    Pena, SDJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) : 177 - 182
12